Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
146.13
-0.76 (-0.52%)
Official Closing Price
Updated: 4:00 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Quest Diagnostics
< Previous
1
2
3
4
5
6
7
8
Next >
5 Value Stocks To Watch In The Healthcare Sector
May 02, 2022
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Analyst Ratings for Quest Diagnostics
April 22, 2022
Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance
April 21, 2022
Via
Benzinga
Quest Diagnostics: Q1 Earnings Insights
April 21, 2022
Quest Diagnostics (NYSE:DGX) reported its Q1 earnings results on Thursday, April 21, 2022 at 06:45 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Quest Diagnostics's Earnings: A Preview
April 20, 2022
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Quest...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
April 18, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Analyst Ratings For Quest Diagnostics
April 04, 2022
Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Quest Diagnostics Secures CDC Contract To Support COVID-19 Research
March 24, 2022
Via
Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.
Via
Benzinga
Earnings Scheduled For April 21, 2022
April 21, 2022
Companies Reporting Before The Bell • Heritage Financial (NASDAQ:HFWA) is likely to report quarterly earnings at $0.37 per share on revenue of $53.22 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
April 04, 2022
Upgrades
Via
Benzinga
Positive Drug Tests Among US Workers Higher Than In Last 20 Years; Does That Include Cannabis?
April 01, 2022
Which of these is correct? The number of cannabis consumers has increased or more people have stopped concealing their consumption as marijuana legalization spreads across the United States?
Via
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Healthcare Stocks to Buy for the Long Term
March 21, 2022
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks.
Via
InvestorPlace
This Foreboding Sign Looms Over Quest Diagnostics's Chart
March 03, 2022
If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
February 28, 2022
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...
Via
Benzinga
What 8 Analyst Ratings Have To Say About Quest Diagnostics
February 14, 2022
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...
Via
Benzinga
Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services
February 03, 2022
Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected
Via
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Quest Diagnostics Q4 Earnings
February 03, 2022
Quest Diagnostics (NYSE:DGX) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
February 02, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09...
Via
Benzinga
7 Undervalued Stocks That Won’t Stay That Way for Long
January 25, 2022
With growing concerns about stability inducing significant fear, contrarians may have an opportunity with undervalued stocks.
Via
InvestorPlace
FeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results
January 17, 2022
--News Direct--
Via
News Direct
26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble
January 14, 2022
There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks.
Via
Talk Markets
Monday Is Your Last Chance To Buy Quest Diagnostics Before The Dividend Payout
January 13, 2022
Monday marks the last chance for investors to receive the next dividend payout from Quest Diagnostics. What's Happening (NYSE:
Via
Benzinga
Quest Diagnostics Inc Slammed After Earnings, Here’s Where It's Going
January 12, 2022
The next major support level for Quest Diagnostics Inc stock will be around the $140.00 level. This support area is where the stock broke out to the upside in early November 2021.
Via
Talk Markets
Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus
January 12, 2022
Quest Diagnostics Inc (NYSE: DGX) expects Q4 sales of $2.74 billion, a decrease of 9% Y/Y, beating the consensus of $2.54 billion. The company noted preliminary Q4...
Via
Benzinga
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
QDEL Stock Alert: What Is Going on With Quidel Today?
December 20, 2021
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result.
Via
InvestorPlace
Price Over Earnings Overview: Quest Diagnostics
December 14, 2021
In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $163.60, after a 0.21% gain. Over the past month, the stock increased by 10.55%, and in the past...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.